Lifecore Biomedical
LFCR
LFCR
86 hedge funds and large institutions have $190M invested in Lifecore Biomedical in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $203M → $190M (-$12.5M)
11% less call options, than puts
Call options by funds: $24K | Put options by funds: $27K
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
86
Holding in Top 10
6
Calls
$24K
Puts
$27K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$1.03M | |
| 3 | +$710K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$456K |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$241K |
Top Sellers
| 1 | -$4.13M | |
| 2 | -$647K | |
| 3 | -$460K | |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$401K |
| 5 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
-$325K |